NCT02704858 2026-03-02
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
Neonc Technologies, Inc.
Phase 1/2 Recruiting
Clinical Trials
9 trialsNCT05023018 2026-03-02
NEO100 and High-Grade Meningioma
Neonc Technologies, Inc.
Phase 2 Recruiting
NCT06357377 2026-01-14
A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors
Neonc Technologies, Inc.
Phase 1 Not yet recruiting
NCT00003219 2019-12-13
Perillyl Alcohol in Treating Patients With Metastatic Breast Cancer
University of Wisconsin, Madison
Phase 2 Completed
NCT00003238 2019-12-13
Perillyl Alcohol in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
University of Wisconsin, Madison
Phase 2 Completed
NCT00608634 2015-04-01
Topical Perillyl Alcohol in Treating Patients With Sun Damaged Skin and Actinic Keratoses
University of Arizona
Phase 2 Completed
NCT00003769 2014-09-10
Perillyl Alcohol Followed by Surgery in Treating Patients With Stage II or Stage III Pancreatic Cancer
Indiana University
Phase 2 Completed
NCT00022425 2013-12-18
Perillyl Alcohol in Preventing Recurrent Breast Cancer in Women Who Have Been Treated With Surgery With or Without Adjuvant Therapy
National Cancer Institute (NCI)
Phase 1 Unknown
NCT00002862 2013-02-11
Perillyl Alcohol in Treating Patients With Refractory Cancer
National Cancer Institute (NCI)
Phase 1 Completed